TR200102771T2 - Kristalleştirme ile elde edilen aglomeralar - Google Patents

Kristalleştirme ile elde edilen aglomeralar

Info

Publication number
TR200102771T2
TR200102771T2 TR2001/02771T TR200102771T TR200102771T2 TR 200102771 T2 TR200102771 T2 TR 200102771T2 TR 2001/02771 T TR2001/02771 T TR 2001/02771T TR 200102771 T TR200102771 T TR 200102771T TR 200102771 T2 TR200102771 T2 TR 200102771T2
Authority
TR
Turkey
Prior art keywords
crystallization
agglomerates
agglomerates obtained
lactum
solvents
Prior art date
Application number
TR2001/02771T
Other languages
English (en)
Inventor
Booij Johannes
Geertruida Lefferts Ageeth
Original Assignee
Dsm N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240058&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200102771(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dsm N. V. filed Critical Dsm N. V.
Publication of TR200102771T2 publication Critical patent/TR200102771T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Abstract

Bu bulus, -laktam bilesiklerinin kristalimsi formdaki yeni aglomeralarini tasvir eder. Ayrica, bahsedilen aglomeralarin hazirlanmasi için bir çözücüde en azindan bir -laktam bilesiginin bir çözeltisinin veya süspansiyonunun, bir veya daha fazla anti-çözücü ile karistirildigi bir islem de anlatilmistir.
TR2001/02771T 1999-04-01 2000-04-03 Kristalleştirme ile elde edilen aglomeralar TR200102771T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99201034 1999-04-01

Publications (1)

Publication Number Publication Date
TR200102771T2 true TR200102771T2 (tr) 2002-04-22

Family

ID=8240058

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02771T TR200102771T2 (tr) 1999-04-01 2000-04-03 Kristalleştirme ile elde edilen aglomeralar

Country Status (12)

Country Link
US (3) US6979735B1 (tr)
EP (1) EP1165049B2 (tr)
CN (1) CN1209099C (tr)
AT (1) ATE260096T1 (tr)
AU (1) AU3817300A (tr)
CA (1) CA2364342C (tr)
DE (1) DE60008508T9 (tr)
ES (1) ES2215628T5 (tr)
MX (1) MXPA01009808A (tr)
SI (1) SI1165049T2 (tr)
TR (1) TR200102771T2 (tr)
WO (1) WO2000041478A2 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
DE60108154T2 (de) * 2000-10-20 2005-12-22 Sandoz Ag Pharmazeutische Zubereitungen enthaltend Clavulansäure
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
US20040132712A1 (en) * 2001-04-12 2004-07-08 Otto Damon Pharmaceutical compositions comprising clavulanic acid
AT500131A1 (de) * 2002-02-01 2005-11-15 Sandoz Ag Organische verbindungen
AT500132A1 (de) * 2002-02-06 2005-11-15 Sandoz Ag Organische verbindungen
AT500134A1 (de) * 2002-02-01 2005-11-15 Sandoz Ag Verfahren zur herstellung eines entmischungsstabilen granulats
AT500133A1 (de) * 2002-02-06 2005-11-15 Sandoz Ag Verfahren zur herstellung eines entmischungsstabilen granulats
US7534781B2 (en) 2003-03-21 2009-05-19 Dsm Ip Assets B.V. Crystalline amoxicillin trihydrate powder
CN1761457B (zh) * 2003-03-21 2010-05-12 帝斯曼知识产权资产管理有限公司 三水羟氨苄青霉素
CA2552632A1 (en) * 2004-01-06 2005-07-21 Panacea Biotec Ltd. Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
US10130678B2 (en) 2014-12-29 2018-11-20 Bioventus, LLC. Systems and methods for improved delivery of osteoinductive molecules in bone repair
CN108905264A (zh) * 2018-07-17 2018-11-30 凯莱英医药集团（天津）股份有限公司 连续化结晶方法在β-内酰胺类抗生素合成中的应用及连续化结晶***
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697506A (en) * 1970-08-07 1972-10-10 Pfizer Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US4138555A (en) * 1971-05-14 1979-02-06 Glaxo Laboratories, Limited (6R,7R)-7-[2-aryl-2-(etherified oximino)acetamido]-3-carbamoyloxymethylceph-3-em-4-carboxylic acid 1-oxides
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos
US3932386A (en) * 1973-06-18 1976-01-13 American Home Products Corporation Sodium 6-(L-aminocyclohexane carboxamido)penicillanic acid
GB1563103A (en) * 1975-10-13 1980-03-19 Beecham Group Ltd Process for the preparation of clavulanic acid
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
US4454069A (en) * 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
US4522701A (en) * 1982-02-11 1985-06-11 E. I. Du Pont De Nemours And Company Process for preparing an anisotropic aromatic pitch
US4456753A (en) * 1983-02-07 1984-06-26 Pfizer Inc. Process for the manufacture of highly crystalline sodium cefoperazone
DE3314725A1 (de) * 1983-04-22 1984-10-25 Siemens AG, 1000 Berlin und 8000 München Oberflaechenwellen-resonatorfilter
US4659812A (en) * 1985-08-20 1987-04-21 Bristol-Myers Company Cephalosporin intermediates
GB8608962D0 (en) * 1986-04-12 1986-05-14 Beecham Group Plc Beta-lactam antibiotics
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
CA1326486C (en) * 1987-01-29 1994-01-25 Dennis Edward Clark Potassium clavulanate
WO1991000865A1 (en) 1989-07-10 1991-01-24 Gema S.A. A novel stable form of cephradine, process for its production and intermediates used therein
GB9009473D0 (en) 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
RU2043988C1 (ru) * 1991-02-12 1995-09-20 Плива Хандельс ГмбХ 4-оксоазетидин-2-сульфоновые кислоты или их соли в качестве промежуточных продуктов в синтезе бета-лактамовых антибиотиков и способ их получения
GB9109862D0 (en) 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT401871B (de) † 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DE4426973C1 (de) * 1994-07-29 1996-03-28 Degussa Verfahren zur Herstellung eines als Brennstoffzellenelektrode einsetzbaren Plattinlegierungskatalysators
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
US6242006B1 (en) 1996-07-16 2001-06-05 Gist-Brocades B.V. β-lactam granules free of organic solvents
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
EP0937084A1 (en) * 1996-11-11 1999-08-25 Gist-Brocades B.V. Process for the preparation of salts and esters of clavulanic acid
ATE187498T1 (de) * 1997-03-24 1999-12-15 Cipan Comp Ind Prod Verfahren zur isolierung eines pharmazeutisch verträglichen alkalimetallsalzes der clavulansäure
EP1023065A1 (en) 1997-08-29 2000-08-02 Dsm N.V. Granules free of excipients

Also Published As

Publication number Publication date
DE60008508T9 (de) 2012-06-14
SI1165049T2 (sl) 2011-11-30
ES2215628T3 (es) 2004-10-16
CN1345231A (zh) 2002-04-17
MXPA01009808A (es) 2002-04-24
DE60008508D1 (de) 2004-04-01
EP1165049A2 (en) 2002-01-02
EP1165049B2 (en) 2011-07-06
SI1165049T1 (en) 2004-12-31
US20110045082A1 (en) 2011-02-24
US20060079496A1 (en) 2006-04-13
US6979735B1 (en) 2005-12-27
DE60008508T3 (de) 2012-01-19
AU3817300A (en) 2000-08-01
CA2364342A1 (en) 2000-07-20
EP1165049B1 (en) 2004-02-25
CN1209099C (zh) 2005-07-06
ES2215628T5 (es) 2011-11-28
CA2364342C (en) 2011-02-01
ATE260096T1 (de) 2004-03-15
DE60008508T2 (de) 2004-12-23
WO2000041478A3 (en) 2000-11-02
WO2000041478A2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
TR200102771T2 (tr) Kristalleştirme ile elde edilen aglomeralar
NO902954L (no) Fremgangsmaate for fremstilling av substituerte kinazolinoner som angiotensin ii-antagonister.
AU5632494A (en) Cyclic derivatives
NO20035201L (no) Optisk opplösning av (1-benzyl-4-metylpiperidin-3-yl)- metylamin og anvendelse derav for fremstilling av pyrrolo 2,3-pyrimidinderivater somprotein kinase inhibitorer
EP1103552A4 (en) BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
CA2334775A1 (en) Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
BRPI0411268B8 (pt) processo para a preparação de compostos 3-aril butil-amina substituído
EP0914130A4 (en) NEW ANTIVIRAL COMPOSITIONS
WO2001017973A3 (de) Neue herbizide
BR0211670A (pt) Processos para a produção de compostos e compostos
WO2003029254A1 (fr) Procede de preparation de composes tricycliques
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
AU4621500A (en) Novel aluminosiloxane compound and process for preparing the same
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU6594900A (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents
YU27099A (sh) Postupak i intermedijari za proizvodnju piridin-2,3- dikarboksilat jedinjenja
DE59910530D1 (de) Herstellung von fluoridarmen organischen verbindungen
BR0000184A (pt) Processo para a preparação de compostos heterocìclicos
IE41394B1 (en) Substituted benimidazoles
CA2279796A1 (en) Process for the preparation of substituted pyridines
AU2319000A (en) Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
BR9910370A (pt) Compostos de cefalosporina, processo para preparar compostos de cefalosporina, e, composições antimicrobianas
DE60111834D1 (de) Verfahren zur herstellung von 3-amino-1,5-benzodiazepinderivaten
DE60108242D1 (de) Herstellung von hydroxyverbindungen
WO2003044877A3 (en) Light emitting device and compounds for use therein